931 - 940 of 8620 Results
Title
Year
-
- Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study2021OPENTitle: Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1464End Page: 1466Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28570Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28570Citation Count: 13
- Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity study2021OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://doi.org/10.1002/brb3.2101Citation Count: 13
-
OPENTitle: Comparison between four published definitions of hyposmia in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2258Citation Count: 7
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
- The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging study2021RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://doi.org/10.1002/epi4.12526Citation Count: 30
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 35
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31